|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 1/34 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3805248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20200642.5 |
| Date of filing the European patent application | 2005-09-08 | |
| (97) | Date of publication of the European application | 2021-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-18 |
| (46) | Date of publication of the claims translation | 2023-04-25 |
| (30) | Number | Date | Country code |
| 609092 P | 2004-09-09 | US | |
| 220362 | 2005-09-06 | US |
| (72) |
WINTER, Charles Matthew , US
|
| (73) |
GENENTECH, INC. ,
1 DNA Way, South San Francisco, CA 94080-4990,
US
Novartis AG , Lichtstrasse 35, 4056 Basel, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų ir jų terapinių produktų koncentravimo procesas |
| PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 20 | 347.00 EUR |